Artificial intelligence care coordination company Viz.ai landed an FDA 510(k) clearance for its new algorithm designed to detect cerebral aneurysms. Dubbed Viz Aneurysm, the technology was designed to pinpoint the condition from CT scans.
The new algorithm will fit into Viz Intelligent Care Coordination Platform, and be used to help streamline getting detected aneurysm into the clinical workflow...
